Search Results - "MERCURI, EUGENIO"

Refine Results
  1. 1

    Spinal muscular atrophy — insights and challenges in the treatment era by Mercuri, Eugenio, Pera, Maria Carmela, Scoto, Mariacristina, Finkel, Richard, Muntoni, Francesco

    Published in Nature reviews. Neurology (01-12-2020)
    “…Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by deletion or mutation of SMN1 . Four subtypes exist, characterized by…”
    Get full text
    Journal Article
  2. 2

    Muscular dystrophies by Mercuri, Eugenio, MD, Muntoni, Francesco, Prof

    Published in The Lancet (British edition) (09-03-2013)
    “…Summary Muscular dystrophies are a heterogeneous group of inherited disorders that share similar clinical features and dystrophic changes on muscle biopsy. An…”
    Get full text
    Journal Article
  3. 3

    Duchenne muscular dystrophy by Duan, Dongsheng, Goemans, Nathalie, Takeda, Shin’ichi, Mercuri, Eugenio, Aartsma-Rus, Annemieke

    Published in Nature reviews. Disease primers (18-02-2021)
    “…Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and, eventually, to the need for assisted…”
    Get full text
    Journal Article
  4. 4

    Risdiplam in Type 1 Spinal Muscular Atrophy by Baranello, Giovanni, Darras, Basil T, Day, John W, Deconinck, Nicolas, Klein, Andrea, Masson, Riccardo, Mercuri, Eugenio, Rose, Kristy, El-Khairi, Muna, Gerber, Marianne, Gorni, Ksenija, Khwaja, Omar, Kletzl, Heidemarie, Scalco, Renata S, Seabrook, Timothy, Fontoura, Paulo, Servais, Laurent

    Published in The New England journal of medicine (11-03-2021)
    “…The small molecule risdiplam increased the expression of SMN protein in blood in 21 infants with type 1 spinal muscular atrophy. Post hoc clinical features of…”
    Get full text
    Journal Article Web Resource
  5. 5

    Childhood spinal muscular atrophy: controversies and challenges by Mercuri, Eugenio, Prof, Bertini, Enrico, MD, Iannaccone, Susan T, Prof

    Published in Lancet neurology (01-05-2012)
    “…Summary Spinal muscular atrophy is an autosomal recessive disorder characterised by degeneration of motor neurons in the spinal cord and is caused by mutations…”
    Get full text
    Journal Article
  6. 6

    The ever-expanding spectrum of congenital muscular dystrophies by Mercuri, Eugenio, Muntoni, Francesco

    Published in Annals of neurology (01-07-2012)
    “…Congenital muscular dystrophies are a highly heterogeneous group of conditions. In the last few years the identification of several new genes encoding for both…”
    Get full text
    Journal Article
  7. 7

    Spinal muscular atrophy by D'Amico, Adele, Mercuri, Eugenio, Tiziano, Francesco D, Bertini, Enrico

    Published in Orphanet journal of rare diseases (02-11-2011)
    “…Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neurons in the spinal cord,…”
    Get full text
    Journal Article
  8. 8

    209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7–9 November 2014, Heemskerk, The Netherlands by Finkel, Richard, Bertini, Enrico, Muntoni, Francesco, Mercuri, Eugenio

    Published in Neuromuscular disorders : NMD (01-07-2015)
    “…Highlights • An updated classification for SMA is presented. • The utility and limitations of animal models in SMA is discussed. • Biomarkers that are…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis by Coratti, Giorgia, Cutrona, Costanza, Pera, Maria Carmela, Bovis, Francesca, Ponzano, Marta, Chieppa, Fabrizia, Antonaci, Laura, Sansone, Valeria, Finkel, Richard, Pane, Marika, Mercuri, Eugenio

    Published in Orphanet journal of rare diseases (13-10-2021)
    “…There is an increasing number of papers reporting the real world use of Nusinersen in different cohorts of SMA patients. Our review suggests that Nusinersen…”
    Get full text
    Journal Article
  10. 10

    Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy by Mendell, Jerry R., Goemans, Nathalie, Lowes, Linda P., Alfano, Lindsay N., Berry, Katherine, Shao, James, Kaye, Edward M., Mercuri, Eugenio

    Published in Annals of neurology (01-02-2016)
    “…Objective To continue evaluation of the long‐term efficacy and safety of eteplirsen, a phosphorodiamidate morpholino oligomer designed to skip DMD exon 51 in…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Antepartum and intrapartum factors preceding neonatal hypoxic-ischemic encephalopathy by Martinez-Biarge, Miriam, Diez-Sebastian, Jesus, Wusthoff, Courtney J, Mercuri, Eugenio, Cowan, Frances M

    Published in Pediatrics (Evanston) (01-10-2013)
    “…To determine whether antepartum factors alone, intrapartum factors alone, or both in combination, are associated with term neonatal hypoxic-ischemic…”
    Get full text
    Journal Article
  13. 13

    Safety update: risdiplam clinical trial programme for spinal muscular atrophy (SMA) by Laurent, Servais, Giovanni, Baranello, Claudia, Chiriboga, Basil, Darras, Marianne, Gerber, Ksenija, Gorni, Birgit, Jaber, Tammy, McIver, Renata, Scalco, Eugenio, Mercuri

    “…Pooled risdiplam (EVRYSDI®) safety data were analysed from 465 symptomatic patients with Types 1–3 SMA in the FIREFISH (NCT02913482), SUNFISH (NCT02908685) and…”
    Get full text
    Journal Article
  14. 14

    JEWELFISH: 24-month safety and pharmacodynamic data in non-treatment- naïve patients with spinal muscular atrophy (SMA) by Mariacristina, Scoto, Claudio, Bruno, Dirk, Fischer, Janbernd, Kirschner, Eugenio, Mercuri, Imogen, Carruthers, Marianne, Gerber, Heidemarie, Kletzl, Teresa, Gidaro, Francesco, Muntoni

    “…Risdiplam (EVRYSDI®) is an oral survival of motor neuron 2 (SMN2) pre-mRNA splicing modifier approved by the EMA and MHRA for the treatment of patients aged ≥2…”
    Get full text
    Journal Article
  15. 15

    Muscle MRI in inherited neuromuscular disorders: Past, present, and future by Mercuri, Eugenio, Pichiecchio, Anna, Allsop, Joanna, Messina, Sonia, Pane, Marika, Muntoni, Francesco

    Published in Journal of magnetic resonance imaging (01-02-2007)
    “…Interest in muscle MRI has been largely stimulated in the last few years by the recognition of an increasing number of genetic defects in the field of…”
    Get full text
    Journal Article
  16. 16

    Risk Factors for Neonatal Arterial Ischemic Stroke: The Importance of the Intrapartum Period by Martinez-Biarge, Miriam, PhD, Cheong, Jeanie L.Y., MD, Diez-Sebastian, Jesus, PhD, Mercuri, Eugenio, PhD, Dubowitz, Lilly M.S., MD, Cowan, Frances M., PhD

    Published in The Journal of pediatrics (01-06-2016)
    “…Objective To investigate risk factors for neonatal arterial ischemic stroke (NAIS), and compare them with those present in term controls and infants with…”
    Get full text
    Journal Article
  17. 17

    Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype by Zollino, Marcella, Orteschi, Daniela, Murdolo, Marina, Lattante, Serena, Battaglia, Domenica, Stefanini, Chiara, Mercuri, Eugenio, Chiurazzi, Pietro, Neri, Giovanni, Marangi, Giuseppe

    Published in Nature genetics (01-06-2012)
    “…Marcella Zollino and colleagues report mutations in the chromatin regulator KANSL1 in persons with 17q21.31 syndrome. This disorder is marked by distinctive…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Application of the Sleep Disturbance Scale for Children (SDSC) in infants and toddlers (6–36 months) by Romeo, Domenico M., Cordaro, Giorgia, Macchione, Elisa, Venezia, Ilaria, Brogna, Claudia, Mercuri, Eugenio, Bruni, Oliviero

    Published in Sleep medicine (01-05-2021)
    “…The aim of the present study is to assess the psychometric properties of the Sleep Disturbance Scale for Children (SDSC) in an Italian population of infants…”
    Get full text
    Journal Article
  20. 20

    Longitudinal natural history of type I spinal muscular atrophy: a critical review by Mercuri, Eugenio, Lucibello, Simona, Perulli, Marco, Coratti, Giorgia, de Sanctis, Roberto, Pera, Maria Carmela, Pane, Marika, Montes, Jacqueline, de Vivo, Darryl C, Darras, Basil T, Kolb, Stephen J, Finkel, Richard S

    Published in Orphanet journal of rare diseases (05-04-2020)
    “…The advent of new therapies in spinal muscular atrophy (SMA) has highlighted the need to have natural history data for comparison. Natural history studies…”
    Get full text
    Journal Article